Concepedia

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Fred Lublin, David H. Miller, Mark S. Freedman, Bruce Cree, Jerry S. Wolinsky, Howard L. Weiner, Catherine Lubetzki, Hans‐Peter Hartung, Xavier Montalbán, Bernard M.J. Uitdehaag,

The Lancet · 2016 · 449 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Rating neurologic impairment in multiple sclerosis

John F. Kurtzke · Neurology · 1983 · 14.9K citations

, , +14

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3.1K citations · Full text

, , +17

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

, , +14

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

, , +15

Adult Norms for the Box and Block Test of Manual Dexterity

Virgil Mathiowetz, Gloria Volland, Nancy Kashman et al. · American Journal of Occupational Therapy · 1985 · 2.1K citations

, , +14